Uncertainties around incretin-based therapies: A literature review
Background: Diabetes mellitus is a chronic debilitating and non-communicable disease. It has several long-term outcomes that are associated with various end organ damage, mainly the heart, blood vessels, eyes, nerves, and kidneys. There are different modalities of treatment of diabetes. The recent i...
Saved in:
Main Authors: | Bader Al Tulaihi (Author), Samia Alhabib (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
by: Joan Khoo, et al.
Published: (2009) -
Tirzepatide - a new analogue of incretin hormones
by: Gabriela Anglart, et al.
Published: (2023) -
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease
by: Federico Bernardini, et al.
Published: (2023) -
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review
by: Teodor Salmen, et al.
Published: (2024) -
Patient perspectives on incretin‐based weight loss medications and relationship with demographic factors
by: Megan A. McVay, et al.
Published: (2024)